{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:41:07Z","timestamp":1792424467094,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-14065-0","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:45:32Z","timestamp":1784706332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of inappropriate empirical antimicrobial therapy on time to hospital discharge in patients with community-acquired acute pyelonephritis: a propensity score-weighted retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7517-1643","authenticated-orcid":false,"given":"Sebasti\u00e1n","family":"Salinas-Mendoza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro Javier Burgos","family":"C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estivalis Geraldine Acosta","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio Velasco","family":"Malagon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"11","key":"14065_CR1","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1007\/s00345-019-03071-4","volume":"38","author":"R \u00d6zt\u00fcrk","year":"2020","unstructured":"\u00d6zt\u00fcrk R, Murt A. Epidemiology of urological infections: a global burden. World J Urol. 2020;38(11):2669\u201379. https:\/\/doi.org\/10.1007\/s00345-019-03071-4.","journal-title":"World J Urol"},{"issue":"5","key":"14065_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269\u201384. https:\/\/doi.org\/10.1038\/nrmicro3432.","journal-title":"Nat Rev Microbiol"},{"issue":"11","key":"14065_CR3","doi-asserted-by":"publisher","first-page":"e2444495","DOI":"10.1001\/jamanetworkopen.2024.44495","volume":"7","author":"Z Nelson","year":"2024","unstructured":"Nelson Z, Aslan AT, Beahm NP, et al. Guidelines for the prevention, diagnosis, and management of urinary tract infections in pediatrics and adults: A WikiGuidelines group consensus statement. JAMA Netw Open. 2024;7(11):e2444495. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.44495.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"14065_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/ndt\/gfad233","volume":"39","author":"S Von Vietinghoff","year":"2024","unstructured":"Von Vietinghoff S, Shevchuk O, Dobrindt U, et al. The global burden of antimicrobial resistance - urinary tract infections. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association -. Eur Ren Association. 2024;39(4):581\u20138. https:\/\/doi.org\/10.1093\/ndt\/gfad233.","journal-title":"Eur Ren Association"},{"key":"14065_CR5","doi-asserted-by":"publisher","unstructured":"Rowe TA, Juthani-Mehta M. Urinary tract infection in older adults. Aging Health. 2013;9(5). https:\/\/doi.org\/10.2217\/ahe.13.38.","DOI":"10.2217\/ahe.13.38"},{"key":"14065_CR6","doi-asserted-by":"publisher","unstructured":"Alviz-Amador A, Gamero-Tafur K, Caraballo-Marimon R, et al. Prevalencia de infecci\u00f3n del tracto urinario, uropat\u00f3genos y perfil de susceptibilidad en un hospital de Cartagena, Colombia. 2016. Revista de la Facultad de Medicina. 2018;66(3):313\u2013317. https:\/\/doi.org\/10.15446\/revfacmed.v66n3.62601.","DOI":"10.15446\/revfacmed.v66n3.62601"},{"issue":"4","key":"14065_CR7","doi-asserted-by":"publisher","first-page":"352","DOI":"10.36104\/amc.2014.270","volume":"39","author":"CP Orrego-Marin","year":"2014","unstructured":"Orrego-Marin CP, Henao-Mejia CP, Cardona-Arias JA. Prevalencia de infecci\u00f3n urinaria, uropat\u00f3genos y perfil de susceptibilidad antimicrobiana. Acta Med Colombiana. 2014;39(4):352\u20138. http:\/\/www.scielo.org.co\/scielo.php?script=sci_abstract. &pid=S0120-24482014000400008&lng=en&nrm=iso&tlng=es.","journal-title":"Acta Med Colombiana"},{"issue":"10474","key":"14065_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0140-6736(24)02081-6","volume":"405","author":"N Macesic","year":"2025","unstructured":"Macesic N, Uhlemann AC, Peleg AY. Multidrug-resistant gram-negative bacterial infections. Lancet. 2025;405(10474):257\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(24)02081-6.","journal-title":"Lancet"},{"key":"14065_CR9","doi-asserted-by":"publisher","unstructured":"Onyango HA, Sloan DJ, Keenan K, et al. The appropriateness of empirical antibiotic therapy in the management of symptomatic urinary tract infection patientsa cross-sectional study in Nairobi County, Kenya. JAC Antimicrob Resist. 2024;6(4). https:\/\/doi.org\/10.1093\/jacamr\/dlae118.","DOI":"10.1093\/jacamr\/dlae118"},{"issue":"5","key":"14065_CR10","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s10096-019-03528-9","volume":"38","author":"SH Kim","year":"2019","unstructured":"Kim SH, Oh S, Huh K, et al. Inappropriate empirical antibiotic therapy does not adversely affect the clinical outcomes of patients with acute pyelonephritis caused by extended-spectrum \u03b2-lactamase-producing enterobacteriales. Eur J Clin Microbiol Infect Dis. 2019;38(5):937\u201344. https:\/\/doi.org\/10.1007\/s10096-019-03528-9.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"14065_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/antibiotics14020197","volume":"14","author":"LC Nocua-B\u00e1ez","year":"2025","unstructured":"Nocua-B\u00e1ez LC, Reyes P, Cortes JA. Effect of inadequate treatment in adult patients with community-acquired acute pyelonephritis due to enterobacterales under empirical management with cefazolin. Antibiotics. 2025;14(2):197. https:\/\/doi.org\/10.3390\/antibiotics14020197.","journal-title":"Antibiotics"},{"key":"14065_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.22354\/24223794.1120","volume":"21","author":"JA Cort\u00e9s","year":"2023","unstructured":"Cort\u00e9s JA, Arenas NC, Blanco JDC, et al. Gu\u00eda de pr\u00e1ctica cl\u00ednica para la infecci\u00f3n de v\u00edas urinarias complicada. Infectio Published online January. 2023;21:52\u201368. https:\/\/doi.org\/10.22354\/24223794.1120.","journal-title":"Infectio Published online January"},{"key":"14065_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/765205","volume":"2012","author":"S Lueangarun","year":"2012","unstructured":"Lueangarun S, Leelarasamee A. Impact of inappropriate empiric antimicrobial therapy on mortality of septic patients with bacteremia: A retrospective study. Interdisciplinary Perspect Infect Dis. 2012;2012:1\u201313. https:\/\/doi.org\/10.1155\/2012\/765205.","journal-title":"Interdisciplinary Perspect Infect Dis"},{"key":"14065_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.7705\/biomedica.v39i1.3981","volume":"39","author":"CA Vargas-Alzate","year":"2019","unstructured":"Vargas-Alzate CA, Higuita-Guti\u00e9rrez LF, Jim\u00e9nez-Quiceno JN, Vargas-Alzate CA, Higuita-Guti\u00e9rrez LF, Jim\u00e9nez-Quiceno JN. Costos m\u00e9dicos directos de las infecciones del tracto urinario por bacilos Gram negativos resistentes a betalact\u00e1micos en un hospital de alta complejidad de Medell\u00edn. Colombia Biom\u00e9dica. 2019;39:35\u201349. https:\/\/doi.org\/10.7705\/biomedica.v39i1.3981.","journal-title":"Colombia Biom\u00e9dica"},{"issue":"2","key":"14065_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jinf.2010.10.009","volume":"62","author":"SS Lee","year":"2011","unstructured":"Lee SS, Kim Y, Chung DR. Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis. J Infect. 2011;62(2):159\u201364. https:\/\/doi.org\/10.1016\/j.jinf.2010.10.009.","journal-title":"J Infect"},{"issue":"5","key":"14065_CR16","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s10096-022-04428-1","volume":"41","author":"TM Benavides","year":"2022","unstructured":"Benavides TM, Aden JK, Giancola SE. Evaluating outcomes associated with revised fluoroquinolone breakpoints for enterobacterales urinary tract infections: A retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2022;41(5):741\u20139. https:\/\/doi.org\/10.1007\/s10096-022-04428-1.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"14065_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3390\/antibiotics13030274","volume":"13","author":"JA Cort\u00e9s","year":"2024","unstructured":"Cort\u00e9s JA, Sierra CR, S\u00e1nchez R. Effect of inappropriate treatment in hospitalized patients with pyelonephritis treated with cefuroxime: A cohort study. Antibiotics. 2024;13(3):274. https:\/\/doi.org\/10.3390\/antibiotics13030274.","journal-title":"Antibiotics"},{"key":"14065_CR18","unstructured":"WHONET. WHONET: Software for microbiology data management and analysis. Published Online 2026. https:\/\/whonet.org."},{"key":"14065_CR19","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","journal-title":"J Biomed Inform"},{"key":"14065_CR20","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing, 32nd ed. CLSI supplement M100. Clinical and Laboratory Standards Institute. Published Online 2021. https:\/\/clsi.org\/shop\/standards\/m100\/."},{"issue":"2","key":"14065_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2307\/2531021","volume":"39","author":"DA Schoenfeld","year":"1983","unstructured":"Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics. 1983;39(2):499. https:\/\/doi.org\/10.2307\/2531021.","journal-title":"Biometrics"},{"issue":"387","key":"14065_CR22","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1080\/01621459.1984.10478078","volume":"79","author":"PR Rosenbaum","year":"1984","unstructured":"Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984;79(387):516\u201324. https:\/\/doi.org\/10.1080\/01621459.1984.10478078.","journal-title":"J Am Stat Assoc"},{"issue":"6","key":"14065_CR23","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/joim.12197","volume":"275","author":"T St\u00fcrmer","year":"2014","unstructured":"St\u00fcrmer T, Wyss R, Glynn RJ, Brookhart MA. Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs. J Intern Med. 2014;275(6):570\u201380. https:\/\/doi.org\/10.1111\/joim.12197.","journal-title":"J Intern Med"},{"key":"14065_CR24","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing; 2026. https:\/\/www.R-project.org\/."},{"key":"14065_CR25","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2147\/idr.s197735","volume":"12","author":"S Th\u00f8nnings","year":"2019","unstructured":"Th\u00f8nnings S, Jans\u00e5ker F, Gradel KO, Styrishave B, Knudsen JD. Cefuroxime compared to piperacillin\/tazobactam as empirical treatment of Escherichia coli bacteremia in a low extended-spectrum beta-lactamase (ESBL) prevalence cohort. Infect Drug Resist. 2019;12:1257\u201364. https:\/\/doi.org\/10.2147\/idr.s197735.","journal-title":"Infect Drug Resist"},{"key":"14065_CR26","doi-asserted-by":"publisher","unstructured":"Xu S, Song Z, Han F, Zhang C. Effect of appropriate empirical antimicrobial therapy on mortality of patients with gram-negative bloodstream infections: a retrospective cohort study. BMC Infect Dis. 2023;23(1). https:\/\/doi.org\/10.1186\/s12879-023-08329-2.","DOI":"10.1186\/s12879-023-08329-2"},{"key":"14065_CR27","doi-asserted-by":"publisher","unstructured":"Chang UI, Kim HW, Wie SH. Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli. Korean J Int Med. 2015;31(1):145\u2013155. https:\/\/doi.org\/10.3904\/kjim.2016.31.1.145.","DOI":"10.3904\/kjim.2016.31.1.145"},{"issue":"4","key":"14065_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.15446\/revfacmed.v63.n4.44185","volume":"63","author":"JA Cortes","year":"2015","unstructured":"Cortes JA, Perdomo D, Morales RA, et al. Gu\u00eda de pr\u00e1ctica cl\u00ednica sobre diagn\u00f3stico y tratamiento de infecci\u00f3n de v\u00edas urinarias no complicada en mujeres adquirida en la comunidad. Revista de la Facultad de Med. 2015;63(4):565\u201381. https:\/\/doi.org\/10.15446\/revfacmed.v63.n4.44185.","journal-title":"Revista de la Facultad de Med"},{"issue":"1","key":"14065_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3947\/ic.2018.50.1.67","volume":"50","author":"CI Kang","year":"2018","unstructured":"Kang CI, Kim J, Park DW, et al. Clinical practice guidelines for the antibiotic treatment of community-acquired urinary tract infections. Infect Chemother. 2018;50(1):67. https:\/\/doi.org\/10.3947\/ic.2018.50.1.67.","journal-title":"Infect Chemother"},{"issue":"1","key":"14065_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1089\/mdr.2013.0075","volume":"20","author":"S Lee","year":"2014","unstructured":"Lee S, Song DY, Cho SH, Kwon KT. Impact of extended-spectrum beta-lactamase on acute pyelonephritis treated with empirical ceftriaxone. Microb Drug Resist. 2014;20(1):39\u201344. https:\/\/doi.org\/10.1089\/mdr.2013.0075.","journal-title":"Microb Drug Resist"},{"key":"14065_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jgar.2021.05.016","volume":"26","author":"H Zhu","year":"2021","unstructured":"Zhu H, Chen Y, Hang Y, et al. Impact of inappropriate empirical antibiotic treatment on clinical outcomes of urinary tract infections caused by escherichia coli: A retrospective cohort study. J Global Antimicrob Resist. 2021;26:148\u201353. https:\/\/doi.org\/10.1016\/j.jgar.2021.05.016.","journal-title":"J Global Antimicrob Resist"},{"issue":"6","key":"14065_CR32","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/s0924-8579(02)00105-x","volume":"19","author":"N Frimodt-M\u00f8ller","year":"2002","unstructured":"Frimodt-M\u00f8ller N. Correlation between pharmacokinetic\/pharmacodynamic parameters and efficacy for antibiotics in the treatment of urinary tract infection. Int J Antimicrob Agents. 2002;19(6):546\u201353. https:\/\/doi.org\/10.1016\/s0924-8579(02)00105-x.","journal-title":"Int J Antimicrob Agents"},{"key":"14065_CR33","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s13104-018-3599-8","volume":"11","author":"DB Chastain","year":"2018","unstructured":"Chastain DB, King ST, Stover KR. Rethinking urinary antibiotic breakpoints: Analysis of urinary antibiotic concentrations to treat multidrug resistant organisms. BMC Res Notes. 2018;11:497. https:\/\/doi.org\/10.1186\/s13104-018-3599-8.","journal-title":"BMC Res Notes"},{"issue":"4","key":"14065_CR34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10096-016-2577-0","volume":"35","author":"BA Cunha","year":"2016","unstructured":"Cunha BA. An infectious disease and pharmacokinetic perspective on oral antibiotic treatment of uncomplicated urinary tract infections due to multidrug-resistant gram-negative uropathogens: The importance of urinary antibiotic concentrations and urinary pH. Eur J Clin Microbiol Infect Dis. 2016;35(4):521\u20136. https:\/\/doi.org\/10.1007\/s10096-016-2577-0.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"16","key":"14065_CR35","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1002\/sim.5705","volume":"32","author":"PC Austin","year":"2012","unstructured":"Austin PC. The performance of different propensity score methods for estimating marginal hazard ratios. Stat Med. 2012;32(16):2837\u201349. https:\/\/doi.org\/10.1002\/sim.5705.","journal-title":"Stat Med"},{"issue":"7","key":"14065_CR36","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1093\/aje\/kwn391","volume":"169","author":"M Lunt","year":"2009","unstructured":"Lunt M, Solomon D, Rothman K, et al. Different methods of balancing covariates leading to different effect estimates in the presence of effect modification. Am J Epidemiol. 2009;169(7):909\u201317. https:\/\/doi.org\/10.1093\/aje\/kwn391.","journal-title":"Am J Epidemiol"},{"key":"14065_CR37","doi-asserted-by":"publisher","unstructured":"Li F, Thomas LE. Addressing extreme propensity scores via the overlap weights. Am J Epidemiol. 2018. https:\/\/doi.org\/10.1093\/aje\/kwy201.","DOI":"10.1093\/aje\/kwy201"},{"issue":"17","key":"14065_CR38","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1002\/sim.10110","volume":"43","author":"T Filla","year":"2024","unstructured":"Filla T, Schwender H, Kuss O. Balancing versus modelling in weighted analysis of non-randomised studies with survival outcomes: a simulation study. Stat Med. 2024;43(17):3140\u201363. https:\/\/doi.org\/10.1002\/sim.10110.","journal-title":"Stat Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14065-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14065-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14065-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:03:18Z","timestamp":1792422198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14065-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14065"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-14065-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Ethics Committee of Fundaci\u00f3n Santa Fe de Bogot\u00e1 (CCEI-8421), and the requirement for informed consent was waived. Data were anonymized before analysis, and the study was conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1822"}}